Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 24;72(1):3-9.
doi: 10.33073/pjm-2023-013. Print 2023 Mar 1.

Probiotics and Prebiotics as Dietary Supplements for the Adjunctive Treatment of Type 2 Diabetes

Yuying Wang  1   2 , Lina Wen  1   2 , Huazhen Tang  1   2 , Jinxiu Qu  1   2 , Benqiang Rao  1   2
Affiliations

Probiotics and Prebiotics as Dietary Supplements for the Adjunctive Treatment of Type 2 Diabetes

Yuying Wang et al. Pol J Microbiol. .

Abstract

In modern lifestyles, high-fat diets and prolonged inactivity lead to more people developing type 2 diabetes (T2D). Based on the modern pathogenesis of T2D, food, and its components have become one of the top concerns for patients. Recent studies have found that dysbiosis and gut-related inflammation are more common in T2D patients. Probiotics and prebiotics play complementary roles in the gut as dietary supplements. Together, they may help improve dysbiosis and intestinal inflammation in people with T2D, increase the production of blood glucose-lowering hormones such as incretin, and help reduce insulin resistance and lower blood glucose. Therefore, changing the dietary structure and increasing the intake of probiotics and prebiotics is expected to become a new strategy for the adjuvant treatment of T2D.

Keywords: microbiota; prebiotics; probiotics; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors do not report any financial or personal connections with other persons or organizations, which might negatively affect the contents of this publication and/or claim authorship rights to this publication.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. AL-Dulaimi M, Algburi A, Abdelhameed A, Mazanko MS, Rudoy DV, Ermakov AM, Chikindas ML Antimicrobial and anti-biofilm activity of polymyxin E alone and in combination with probiotic strains of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 against clinical isolates of selected Acinetobacter spp.: a preliminary study Pathogens. 2021 NaN10(12):1574. doi: 10.3390/pathogens10121574. . . ; ( ): - DOI - PMC - PubMed
    1. Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, Korennykh A, Donia MS The human microbiome encodes resistance to the antidiabetic drug acarbose Nature. 2021 NaN600(7887):110. doi: 10.1038/s41586-021-04091-0. . . ; ( ): –. - DOI - PMC - PubMed
    1. Bock PM, Telo GH, Ramalho R, Sbaraini M, Leivas G, Martins AF, Schaan BD The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis Diabetologia. 2021 NaN64(1):26. doi: 10.1007/s00125-020-05295-1. . . ; ( ): –. - DOI - PubMed
    1. Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, Baron A, Fineman M The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies Diabetes Care. 2016 NaN39(2):198. doi: 10.2337/dc15-0488. . . ; ( ): –. - DOI - PubMed
    1. Canfora EE, Meex RCR, Venema K, Blaak EE Gut microbial metabolites in obesity, NAFLD and T2DM Nat Rev Endocrinol. 2019 NaN15(5):261. doi: 10.1038/s41574-019-0156-z. . . ; ( ): –. - DOI - PubMed